WNT1 and rheumatoid arthritis: To sum up, the aforementioned findings revealing the crucial impact of the Wnt1/β‐catenin signalling pathway in RA progression and the inhibitory effect of berberine on this pathway accompanied by amelioration of RA clinical complications suggest the potential of Wnt1/β‐catenin signalling mediators as the effective therapeutic targets for treating RA.